Insider Transactions in Q1 2019 at Accenture PLC (ACN)
Insider Transaction List (Q1 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
30
+0.07%
|
$4,890
$163.22 P/Share
|
|
Mar 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125
+0.62%
|
$20,375
$163.22 P/Share
|
|
Mar 05
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.63%
|
$16,300
$163.22 P/Share
|
|
Mar 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
161
+0.56%
|
$26,243
$163.22 P/Share
|
|
Mar 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
153
+0.12%
|
$24,939
$163.22 P/Share
|
|
Mar 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.47%
|
$16,300
$163.22 P/Share
|
|
Mar 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
149
+0.42%
|
$24,287
$163.22 P/Share
|
|
Mar 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
87
+0.46%
|
$14,181
$163.22 P/Share
|
|
Mar 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
174
+0.14%
|
$28,362
$163.22 P/Share
|
|
Mar 01
2019
|
David Rowland Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
13,706
+26.46%
|
-
|
|
Feb 11
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Indirect |
1,000
-90.0%
|
$156,000
$156.08 P/Share
|
|
Feb 11
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct |
1,000
-0.38%
|
$156,000
$156.08 P/Share
|
|
Feb 07
2019
|
Jaime Ardila Director |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-3.15%
|
$61,535
$155.09 P/Share
|
|
Feb 07
2019
|
Herbert Hainer Director |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-13.88%
|
$143,995
$155.09 P/Share
|
|
Feb 07
2019
|
Marjorie Magner Director |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-2.75%
|
$73,160
$155.09 P/Share
|
|
Feb 07
2019
|
Nancy Mc Kinstry Director |
SELL
Payment of exercise price or tax liability
|
Direct |
821
-15.34%
|
$127,255
$155.09 P/Share
|
|
Feb 07
2019
|
Gilles Pelisson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-10.13%
|
$143,995
$155.09 P/Share
|
|
Feb 07
2019
|
Paula A Price Director |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-6.04%
|
$73,160
$155.09 P/Share
|
|
Feb 07
2019
|
Arun Sarin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-7.93%
|
$73,160
$155.09 P/Share
|
|
Feb 07
2019
|
Frank Kui Tang Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,132
-11.66%
|
$175,460
$155.09 P/Share
|
|
Feb 07
2019
|
Tracey Thomas Travis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
611
-13.98%
|
$94,705
$155.09 P/Share
|
|
Feb 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.08%
|
$4,836
$156.98 P/Share
|
|
Feb 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
129
+0.65%
|
$20,124
$156.98 P/Share
|
|
Feb 05
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
103
+0.65%
|
$16,068
$156.98 P/Share
|
|
Feb 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
167
+0.58%
|
$26,052
$156.98 P/Share
|
|
Feb 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
155
+0.12%
|
$24,180
$156.98 P/Share
|
|
Feb 05
2019
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.3%
|
$9,828
$156.98 P/Share
|
|
Feb 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155
+0.43%
|
$24,180
$156.98 P/Share
|
|
Feb 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
90
+0.47%
|
$14,040
$156.98 P/Share
|
|
Feb 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
180
+0.14%
|
$28,080
$156.98 P/Share
|
|
Feb 01
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
838
-2.01%
|
$129,052
$154.44 P/Share
|
|
Feb 01
2019
|
Jaime Ardila Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,233
+15.05%
|
-
|
|
Feb 01
2019
|
Richard P Clark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
654
-3.22%
|
$100,716
$154.44 P/Share
|
|
Feb 01
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,712
+32.34%
|
-
|
|
Feb 01
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
699
-0.9%
|
$107,646
$154.44 P/Share
|
|
Feb 01
2019
|
Herbert Hainer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,136
+24.19%
|
-
|
|
Feb 01
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,607
-5.38%
|
$247,478
$154.44 P/Share
|
|
Feb 01
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Payment of exercise price or tax liability
|
Direct |
2,512
-1.87%
|
$386,848
$154.44 P/Share
|
|
Feb 01
2019
|
Marjorie Magner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,654
+13.37%
|
-
|
|
Feb 01
2019
|
Kathleen R Mc Clure Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-0.69%
|
$22,484
$154.44 P/Share
|
|
Feb 01
2019
|
Nancy Mc Kinstry Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,780
+24.96%
|
-
|
|
Feb 01
2019
|
Gilles Pelisson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,136
+18.89%
|
-
|
|
Feb 01
2019
|
Paula A Price Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,359
+14.8%
|
-
|
|
Feb 01
2019
|
Venkata S M Renduchintala Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,104
+34.07%
|
-
|
|
Feb 01
2019
|
David Rowland Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,975
-10.87%
|
$458,150
$154.44 P/Share
|
|
Feb 01
2019
|
Arun Sarin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,359
+18.59%
|
-
|
|
Feb 01
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-2.62%
|
$146,762
$154.44 P/Share
|
|
Feb 01
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct |
1,172
-3.12%
|
$181,660
$155.0 P/Share
|
|
Feb 01
2019
|
Julie Spellman Sweet Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,301
-5.19%
|
$508,354
$154.55 P/Share
|
|
Feb 01
2019
|
Frank Kui Tang Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,072
+17.59%
|
-
|